Weather Afternoon: 10°c Sunny spells Tonight: 4°c Partly Cloudy Night

Business

pills

Generic drugs industry is damaged by quality fears

Lucy Tobin
3 Jul 2009


The UK's medical watchdog has recalled multiple generic drugs from Britain's pharmacy shelves due to "serious" deficiencies, in a move that threatens to damage the reputation of non-branded medicines.

After an inspection of an Indian firm's manufacturing plant, the Medical and Healthcare Products Regulatory Agency said its production methods for generic drugs sold in the UK, including a version of the anti-depressant Prozac made by Swiss giant Novartis, failed the minimum standards set by the European Union.

Other drugs involved in the recall included hypertension pills, diabetes medicine and pain-relieving drugs.

The agency's inspectors said they found "inaccuracies contained in documents such as batch manufacturing and testing records" but maintained that, "at present, there is no specific evidence to suggest that the medicines are not safe for patient use".

With generics making up more than a fifth of the UK's pharmaceuticals market, including supplying 22% of NHS-dispensed medicines, Big Pharma could benefit from a potential backlash by consumers concerned about the drugs' safety.

Earlier this year, AstraZeneca had a sales boost to its blood pressure drug Toprol XL when one of its generic rivals was criticised by the US watchdog the Food and Drug Administration, and then taken off the market.

Reader views (2)

 Add your view

If its cheap; the government like it for the masses.

Its not a worry for them; they go private mostly.

I was wondering about Margeret Thatcher during the last few weeks in hospital; did she go NHS or Private?

Not that it matters to me in anyway- but she did want the NHS destroyed; and Private medical health services to become the norm; much like in the USA etc.

so I wondered if she used the NHS or BUPA etc.

Most get chucked out of hospital fast these days; but she had a couple of weeks in Chelsea etc, so I assume it wasn't on the NHS.

- Mickinlondon, london., 03/07/2009 14:12
Report abuse

That's scary.. are they safe?

- Kate, hants, uk, 03/07/2009 11:47
Report abuse


Add your comment

 

Terms and conditions Make text area bigger You have  characters left.

We welcome your opinions. This is a public forum. Libellous and abusive comments are not allowed. Please read our House Rules.

For information about privacy and cookies please read our Privacy Policy.


 

 

  • Slump looms in eurozone as economy takes a dive Euro Europe's lingering debt crisis has pushed the eurozone closer to recession as the beleaguered single currency bloc's economy shrank for the...
  • Sports Direct is on right track Mike Ashley Sports Direct is on track to hit its "super-stretch" profit targets this year, passing the first hurdle that could see it hand founder Mike...
  • Bank may turn off printing presses as inflation drops Mervyn King The Bank of England's latest £50 billion burst of quantitative easing may be the last time it needs to resort to the printing presses
  • Online orders on mobiles lift Domino's Pizza Domino's Pizza UK said its online sales have powered ahead to account for more than half of delivered sales
  • Debt deadline: Greece on brink Hopes were rising that Greece will sign up to the first €130 billion (£109 billion) bailout from the European Union and International Monetary Fund
  • Frothy profits at Heineken Beer The economy might be in dire straits but Brits still love a pint down the pub
  • French banks face battering on exposure to Greek debt French banks look set to take one of the biggest haircuts on Greek debt as the country's largest, BNP Paribas, has said it had raised its provisions on Greek sovereign bonds to 75%
  • Thorntons calls in a former Gunner to help turnaround Thorntons The chocolatier Thorntons has turned to the former boss of Arsenal football club to turn around its fortunes
  • LandSecs £1bn joint venture for Victoria A £1 billion-plus redevelopment is on the way at Victoria station
  • Morgan Crucible results surge on emerging market growth Morgan Crucible reported highest-ever full-year results, helped by strong performance across both its divisions, and reiterated that 2012 growth would be driven by new products and emerging markets
  •  
    Market Roundup
    WEDNESDAY UPDATE

    Barclaycard's exit leaves CPP with an identity crisis

    Bye bye Barclaycard. Nearly a year since the FSA started investigating CPP over its sales techniques, the identity theft protection firm touched a new, all-time low today after admitting it was losing one of its most high-profile clients

    More